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Edited by Barry HalliwellAbstract Cholesterol, a major neutral lipid component of bio-
logical membranes and the lung epithelial lining ﬂuids, is suscep-
tible to oxidation by reactive oxygen and nitrogen species
including ozone. The oxidation by ozone in biological environ-
ments results in the formation of 3b-hydroxy-5-oxo-5,6-secoc-
holestan-6-al (cholesterol secoaldehyde or CSeco, major
product) along with some other minor products. Recently, CSeco
has been implicated in the pathogenesis of atherosclerosis and
Alzheimers disease. In this communication, we report that CSe-
co induces cytotoxicity in H9c2 cardiomyoblasts with an IC50 of
8.9 ± 1.29 lM (n = 6). The observed eﬀect of CSeco at low
micromolar concentrations retained several key features of apop-
tosis, such as changes in nuclear morphology, phosphatidylserine
externalization, DNA fragmentation, and caspase 3/7 activity.
Treatment of cardiomyocytes with 5 lM CSeco for 24 h, for in-
stance, resulted in 30.8 ± 3.28% apoptotic and 1.8 ± 1.11% of
necrotic cells as against DMSO controls that only showed
1.3 ± 0.33% of apoptosis and 1.6 ± 0.67% of necrosis. In gen-
eral, the loss of cellular viability paralleled the increased occur-
rence of apoptotic cells in various CSeco treatments. This study,
for the ﬁrst time, demonstrates the induction of apoptotic cell
death in cardiomyocytes by a cholesterol ozonation product,
implying a role for ozone in myocardial injury.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Cholesterol is one of the most abundant neutral lipids in
the biological membranes and is a component of pulmonary
surfactant [1]. The D5,6 double bond in cholesterol is suscep-
tible to oxidation by reactive oxygen and nitrogen species
including ozone [2]. The reaction with ozone has been shown
to form several products including a major product, 3b-hy-
droxy-5-oxo-5,6-secocholestan-6-al [cholesterol secoaldehyde
(CSeco) (Fig. 1)]. CSeco has been detected in lung homoge-
nates and bronchoalveolar lavage ﬂuid of rats exposed to*Corresponding author. Fax: +1 225 771 5350.
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for ozone exposure [5]. A recent report by Wentworth
et al. [6] demonstrates the formation of CSeco in arterial
plaques following treatment with phorbol esters indicating
the production of endogenous oxidants under inﬂammatory
conditions. CSeco formed in reactions of ozone with choles-
terol in lung surfactant has been shown to be cytotoxic to
human bronchial epithelial cells [7]. Other oxysterols similar
to CSeco but produced in autoxidation reactions have been
shown to be cytotoxic to numerous cell types [8] and have
been known to play an important role in the development
of cardiovascular diseases [9]. The relation between ozone
and myocardial diseases has been reported in several epide-
miological studies [10,11]. Reports concerning the cytotoxic-
ity of CSeco eﬀecting the cardiovascular system have
however been limiting. Therefore in the present study, exper-
iments were conducted to delineate the eﬀects of CSeco on
cardiomyocytes. It was observed that CSeco induced apopto-
tic cell death at low micromolar concentrations. The apopto-
sis increased in a dose-dependant manner indicating that
CSeco may probably be involved in myocardial injury, and
is reported in the present communication.2. Materials and methods
2.1. Synthesis of CSeco
The synthesis of CSeco was performed according to the method of
Wang et al. [3]. Brieﬂy, 1 mmol of cholesterol (>99%; Sigma) was dis-
solved in 150 ml of dichloromethane/methanol (1/1, v/v). A gentle
stream of ozone (4 mmol/h) in oxygen (300 ml/min), generated by San-
der 200 ozonizer (Erwin Sander, Uetze-Eltze, Germany), was allowed
to bubble through the cholesterol solution until P 99% of cholesterol
was oxidized. The extent of oxidation of cholesterol was assessed by
reversed phase (RP) HPLC on a Discovery HS C18 column
(4.6 mm · 250 mm) using a mobile phase that contained 40% isopropa-
nol in acetonitrile at a ﬂow of 1 ml/min (the eluent was monitored at
210 nm). Upon veriﬁcation that cholesterol was completely oxidized,
the sample was reduced with Zn/AcOH and puriﬁed by solvent extrac-
tion [3]. The purity of the ﬁnal product was tested by RP-HPLC. Stock
solutions of the ﬁnal product were prepared in DMSO at a concentra-
tion of 20 mM and stored in small aliquots at 80 C until use.
2.2. Cell culture
Rat heart cell line H9c2 was obtained from ATCC (Rockville, MD).
The cells were cultured at 37 ± 0.5 C in 5% CO2 in DMEM containing
4 mM glutamine, 1.5 g/l sodium bicarbonate, 4.5 g/l glucose, 1.0 mM
sodium pyruvate, 10% FBS, 100 U/ml penicillin, and 100 lg/mlation of European Biochemical Societies.
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Fig. 1. Structure of CSeco.
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prevent the loss of diﬀerentiation potential, the cells were not allowed
to become conﬂuent. The cells at ca. 70% conﬂuence were exposed to
varying concentrations of CSeco in a medium that contained 2% FBS
and antibiotics. Care was taken to see that the ﬁnal concentration of
DMSO in the control as well as cell cultures exposed to CSeco was
always 60.01% (v/v).
2.3. Cell viability
A non-radioactive assay, CellTiter 96 AQueous from Promega (Mad-
ison, WI) was used to assess cell viability or proliferation. The assay
was based on the reduction of a water-soluble tetrazolium salt 3-(4,
5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-
2H-tetrazolium (MTS) by viable cells in a phenazine methosulfate
(PMS)-assisted reaction. The H9c2 cultures (500 ll each) in DMEM
were seeded in 24-well culture plates (Corning, Acton, MA) at
3 · 104 cells/well. The medium was replaced with DMEM containing
2% FBS, antibiotics, and varying concentrations of CSeco (0–25 lM)
and the incubation continued for 24 h. At the end of the incubation
period, an aliquot (20 ll) of the MTS/PMS reagent (20:1) supplied
by the manufacturer was added per well. The cells were incubated
for 4 h and the MTS formazan produced was measured at 490 nm
using a Biotek EL 800 microplate reader. Background absorbance
from wells that contained CSeco in DMEM but no added cells was
subtracted. The viability of cells not exposed to CSeco was set to
100% and the viability in CSeco-treated cultures was expressed relative
to the controls.
2.4. Release of cytosolic lactate dehydrogenase
Release of cytoplasmic LDH is a means of measuring membrane
integrity. We performed this assay in cardiomyocytes exposed to CSe-
co using CytoTox-ONE homogeneous membrane integrity kit fromFig. 2. Structure and fragmentation pattern of the mPromega (Madison, WI). After exposing cardiomyocytes to diﬀerent
concentrations of CSeco (0–25 lM) for 24 h, the culture plates were
centrifuged at 250 · g for 4 min. An aliquot (100 ll) of the supernatant
was transferred to a clean, ﬂat-bottomed black well plate and 100 ll
CytoTox-ONE reagent was added. The plates were protected from
light and incubated at room temperature for 10 min. The ﬂuorescent
signal was measured at an excitation wavelength of 560 nm and an
emission wavelength of 590 nm. The LDH release is expressed as per-
centage of total LDH (i.e., following complete lysis of cells).
2.5. Morphological staining using acridine orange and ethidium bromide
Acridine orange (AO) stains DNA bright green and, therefore, al-
lows visualization of chromatin pattern in apoptotic and necrotic cells.
Ethidium bromide (EB) stains DNA orange but is excluded by viable
cells. Dual staining with AO-EB thus allows enumeration of popula-
tions of cells that are viable-non-apoptotic, viable-apoptotic, non-
viable-apoptotic, and necrotic. We performed the AO-EB assay in
cardiomycytes exposed to CSeco as described by Agrawal et al. [12].
Brieﬂy, cardiomyocytes treated with CSeco (5 and 10 lM) for 24 h
were trypsinized, and cell pellets were collected by centrifugation at
300 · g, resuspended in 50 ll of complete medium and stained with
4 ll of AO-EB working solution (AO: 100 lg/ml; EB: 100 lg/ml) in
0.9% saline. Samples were analyzed immediately by ﬂuorescence
microscopy (excitation: 488 nm; emission: 520 nm). Percentage of total
apoptosis was obtained from the sum of viable apoptotic and nonvia-
ble apoptotic cells divided by the total number of cells.
2.6. DNA fragmentation
Cardiomyocytes in 24-multiwell plates were treated with various
concentrations of CSeco for 24 h. The cytoplasmic histone-associated
DNA fragments, which are indicative of apoptosis, were measured
using sandwich ELISA (Cell Death Detection kit, Roche; Indianapolis,
IN). Brieﬂy, cells were lysed and the lysate was added to streptavidin-
coated 96-well plates. A mixture of biotinylated anti-histone and
peroxidase-coupled anti-DNA antibodies was added, incubation con-
tinued for 2 h at room temperature, and then washed. The amount
of cytoplasmic nucleosome was quantiﬁed based on the formation of
2,3-diaminophenazine at 405 nm. The relative yields of apoptosis were
determined based on the ratio of absorbance in the wells with CSeco-
treated cells versus those with control, untreated cells. Results were
averaged from three diﬀerent experiments performed in duplicate.
2.7. Caspase-3/7 protease activity
Cardiomyocytes in 24 well plates were treated with 0–25 lM CSe-
co for 24 h. Upon lysis of cardiomyocytes, the activity of caspase 3/
7 was determined based on proteolytic cleavage of rhodamine 110,
bis-(N-CBZ-L-aspartyl-L-glutamyl-L-valyl-L-aspartic acid amide) (Z-
DEVD-R110) (Apo-ONE Homogeneous Caspase-3/7 Assay kit;
Promega, Madison, WI). The sequential cleavage and removal ofolecular ion of CSeco formed in GC/MS/EI.
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rhodamine 110, which is quantiﬁed using Spectermax Gemini ﬂuo-
rescence spectrophotometer (excitation: 499 nm; excitation:
521 nm). Caspase 3/7 activity is expressed as number of folds in-
crease relative to untreated control.
2.8. Annexin-V/propidium iodide assay
Phosphatidylserine (PS) translocation resulting in loss of plasma
membrane asymmetry and changes in nuclear morphology, that
are characteristic of apoptotic process, were performed using annex-
in-V-FLUOS staining kit (Roche, Indianapolis, IN). Cardiomyocytes
grown to subconﬂuency on cover slips were treated with diﬀerent
concentrations of CSeco for 24 h. The cells were then incubated
with annexin-V-FITC conjugate and propidium iodide for 15 min
at room temperature in a buﬀer that facilitates binding. At the
end of incubation, digital images were taken using a Nikon E400
ﬂuorescence microscope and image capture were performed using
SPOT Advanced software (Diagnostic Instruments, Sterling Heights,Fig. 3. Eﬀect of CSeco on cardiomyocytes. (A) Induction of morphologic ch
(control), (b) 5 lM, (c) 10 lM and (d) 25 lM. Cardiomyocytes were exami
CSeco exposure decreases cellular viability of cardiomyocyes in the MTS red
for 24 h. Cell viability measured using CellTiter 96 AQueous kit.MI). Cells were examined for changes in the plasma membrane and
nuclear morphology and were compared with diﬀerent treatments to
qualitatively conﬁrm apoptosis.
2.9. Statistical analysis
Values of IC50 were calculated by ﬁtting the log concentration–re-
sponse curves by standard non-linear regression analysis using Prism
4.0 (GraphPad Software, San Diego, CA). All data are expressed as
means ± SEM from three or more independent experiments.3. Results
3.1. Synthesis of cholesterol secoaldehyde
A convenient method for the synthesis of CSeco, described
by Wang et al. [3], involves ozonation of cholesterol in aanges and cell death in cardiomyocytes treated with CSeco at (a) none
ned by phase-contrast microscopy after 24 h of CSeco treatment. (B)
uction assay. Cells were treated with diﬀerent concentrations of CSeco
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Fig. 4. Eﬀect ofCSecoonLDHrelease.Cardiomyocyteswere incubated
with the indicated CSeco concentrations for 24 h. Results are expressed
as percentages of LDH release after subtracting the control values. Data
are means ± SEM of four separate experiments from cells of diﬀerent
cultures, each one performed in triplicate.
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mixture with Zn/AcOH. We have used a similar methodol-
ogy but employed RP-HPLC instead of TLC to monitor
the progress of ozonation. The use of RP-HPLC allows a
rapid and accurate monitoring of unreacted cholesterol in
the ozonation mixtures. In addition to carbon–carbon dou-
ble bounds, ozone is known to react with carbon–hydrogen
bounds in aliphatic hydrocarbons with the selectivity being
more for tertiary than for secondary and primary alkanes
[13]. The second-order rate constants for the reaction of
ozone with carbon–carbon double bonds, in general, are sev-
eral orders of magnitude higher than for carbon–hydrogen
bonds [13]. Therefore, the oxidation of C–H bonds of cho-
lesterol that is likely to occur at C8, C9, C13, C17, C20,
and C25 positions can be minimized by controlled ozona-
tion. We performed high resolution mass spectral analysis
as well as GC/MS/EI fragmentation on CSeco synthesized.
The exact mass was 418.340692 which compares well with
the expected value of 418.344696. The GC/MI/EI fragmenta-
tion showed a molecular ion (M+) at m/z 418, and daughter
fragments at m/z 128, 110, and 93. The fragmentation pat-
tern is outlined schematically in Fig. 2.3.2. CSeco is a potent inducer of cytotoxicity in cardiomyocytes
The MTS reduction assay shown in Fig. 3A indicates a
marked induction of cell death in cardiomyocytes treated
with varying low concentrations of CSeco for 24 h. The
concentration of CSeco required for 50% cell death was
calculated from the dose–response curve. It was found to
be 8.9 ± 1.29 lM (n = 6). Microscopic evaluations of cell cul-
tures revealed a signiﬁcant loss of cell survival at each
concentration of CSeco. Also, there were major morpholog-
ical changes such as cell shrinkage and membrane blebbing
(Fig. 3B).3.3. Cytosolic LDH release
CSeco induces LDH release to the extracellular medium
only at concentrations P 25 lM (Fig. 4). After 24 h of
exposure, doses of 1–10 lM CSeco did not induce any
signiﬁcant LDH release. This conﬁrms that CSeco does not
induce changes in cellular integrity at concentrations lower
than 10 lM.3.4. Cholesterol secoaldehyde induces apoptosis in
cardiomyocytes
The images of cardiomyocytes shown in Fig. 5A were ob-
tained after staining with AO and EB. Treatment with CSe-
co at concentrations of 5 and 10 lM for 24 h resulted in
higher proportion of cells with dying nuclei than in control
cells. At 5 lM CSeco, there were 30.8 ± 3.28 apoptotic and
1.8 ± 1.11% necrotic cells as against DMSO controls that
only showed 1.3 ± 0.33% of apoptosis and 1.6 ± 0.67% of
necrosis. The % apoptotic and necrotic cells at 10 lM CSeco
were 56.9 ± 5.97 and 3.4 ± 0.94, respectively (Fig. 5B). The
condensed chromatin that stained uniformly and the cellular
integrity indicated that the cell death is typical of apoptosis.
We used three diﬀerent assays to further conﬁrm the
occurrence of apoptosis. These include DNA fragmentation,
caspase 3/7 activity, and staining with annexin-V/propidium
iodide. Treatment of cardiomyocytes with CSeco resulted
in a dose-dependent increase in the histone associated cyto-plasmic DNA fragments, with the highest level being ob-
served around 10 lM CSeco. There was less DNA
fragmentation, but increased cell death at concentrations
of CSeco P 25 lM, indicating a change from apoptotic to
necrotic cell death at higher concentrations (Fig. 6). It was
found that CSeco concentrations of 1–10 lM which pro-
moted DNA fragmentation also induced a dose-dependent
activation of caspase 3/7, with maximal activity observed
at 10 lM CSeco (Fig. 7). There was a signiﬁcant loss of
plasma membrane asymmetry due to phosphatidylserine
translocation in cardiomyocytes treated with 5 and 10 lM
CSeco for 24 h but not in the control cells (Fig. 8).4. Discussion
The major ﬁnding of this study is that CSeco, a cholesterol
ozonation product induces a dose-dependent apoptosis in
H9c2 cardiomyoblasts. The mechanism of apoptosis is not
clear; however, in analogy with other oxysterols, the apoptotic
process could involve derangement in cholesterol homeostasis
[14], alterations in cell-cycle regulation [15], and/or changes in
inﬂammatory signaling [16].
The cytotoxic eﬀects of CSeco may have a clinical implica-
tion, especially in the light of recent reports demonstrating
the occurrence of CSeco in the atherosclerotic plaques [6]
and in brain samples of patients with Alzheimers disease
[17]. Wentworth and his coworkers detect 60 pmol of CSeco
per mg of human atherosclerotic plaque [6]. Assuming an
approximate density of 1 g/ml, the concentration of CSeco in
the lesion material would equate to 60 lM. This concentration
is about one-order of magnitude higher than the IC50 reported
in the present study, meaning that cholesterol ozonation prod-
ucts may increase the risk of myocardial injury.
The biochemical origin as well as the metabolic fate of
ozone-speciﬁc oxysterols is largely unknown. Babior et al.
[18] and Wenworth et al. [6] suggest that ozone produced
at the inﬂammatory sites reacts with cholesterol resulting
in the formation of CSeco. The other possibility is that
ozone in the breathing air oxidizes cholesterol at the air/lung
interface and the products formed are then transported to
Fig. 5. (A) Induction of apoptosis in cardiomyocytes treated with CSeco: (a) Control cells (b) and (c) cardiomyocytes treated with 5 and 10 lM of
CSeco (respectively) for 24 h. Apoptosis was detected using AO and EB morphological staining, and the ﬂuorescence was observed using a
ﬂuorescence microscope. (B) Percentage of cardiomyocytes undergoing apoptosis/necrosis evaluated by AO/EB double staining following CSeco
treatment after 24 h incubation.
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Fig. 6. Quantiﬁcation of DNA fragmentation by measuring the
cytoplasmic histone-associated DNA by sandwich ELISA. Cardio-
myocytes are exposed to varying concentrations of CSeco for 24 h.
Data are expressed relative to control values and are given as
means ± SEM from ﬁve separate experiments.
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Fig. 7. Eﬀect of CSeco on caspase-3/7 activity. Cardiomyocytes were
treated with diﬀerent CSeco concentrations. Results are expressed
relative to control values. Data are means ± SEM of four separate
experiments.
6448 K. Sathishkumar et al. / FEBS Letters 579 (2005) 6444–6450
Fig. 8. Annexin V-FITC/propidium iodide staining photomicrographs: (A) untreated control cells; (B) and (C) cells treated with 5 and 10 lMCSeco
for 24 h (respectively). Cardiomyocytes were stained using Annexin-V-FLUOS staining kit as described in Section 2.
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colleagues [5,19]. Epidemiological studies indicate a link be-
tween ozone pollution and increased risk of myocardial
infarction, coronary atherosclerosis, and pulmonary heart
disease [10,11] and increased frequency of hospitalizations
among the elderly [20]. Experimental studies also show that
ozone exposure by inhalation causes sphering and increased
osmotic fragility of erythrocytes [21], damage to the mem-
branes and nuclei of myocardial ﬁbers [22], and changes in
brain serotonin levels [23], meaning that ozonation products
formed at the air/lung interface can inﬂict damage to
peripheral tissues and organs [24].
Pulfer and Murphy [7] have shown that exposure of lung
surfactant to 2 ppm ozone produces three diﬀerent types
of oxysterols, namely, CSeco, 5-hydroperoxy-B-homo-6-
oxa-cholestan-3b,7a-diol, and 5b,6b-epoxycholesterol [4,7].
5-Hydroperoxy-B-homo-6-oxa-cholestan-3b,7a-diol and 5b,
6b-epoxycholesterol have been shown to be cytotoxic to hu-
man bronchial epithelial cells [7]. According to Pulfer and
Murphy [7], the yields of CSeco are lower than the other two
sterols in ozone-exposed lung surfactant. The diﬀerences may
not be signiﬁcant when issues of cytotoxic potentials are con-
sidered. For instance, the concentration of CSeco at IC50
(8.9 ± 1.29 lM) is about half of that reported for hydroper-
oxy-B-homo-6-oxa-cholestan-3b,7a-diol (15 ± 8 lM). There-
fore, the cytotoxicity observed in cardiomyocytes provide
evidence for the biological eﬀects of oxysterols produced in
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